Investigation of Serum Oxidized Low-Density Lipoprotein IgG Levels in Patients with Angiographically Defined Coronary Artery Disease

Table 1

Demographic and clinical characteristics of CAD⁺, CAD⁻, and control subjects.

	CAD^+	CAD^−	Control
Number of subjects	31	32	24
Gender (F/M)	19/12^f	17/15	6/18
Age	59.39±10.14	58.34±9.68	58.25±9.19
Height	159.07±8.54^a	157.83±11.99^b	167.10±7.77
Weight	69.71±11.93	64.40±14.48^b	75.74±12.67
FBS	138.07±81.75	99.14±28.34	94.18±16.62
BMI	27.39±3.63	26.05±6.87	27.60±4.28
Waist/hip ratio	0.94±0.08	0.94±0.07	0.95±0.16
Waist circumference	88.28±9.54^a	88.77±13.55^a	99.16±19.01
Hip circumference	93.88±8.39^b	94.12±12.44^b	105.32±15.86
LDL-C	90.67±31.84	107.57±46.99	106.78±20.17
HDL-C	40.60±15.91	38.88±10.88	64.70±88.93
TG	123.69 (47.00–331.00)	157.00 (41.00–352.00)	146.65 (53.00–325.00)
SBP	156.45±30.30^c	154.08±28.18^c	123.92±10.59
DBP	77.87±14.47	76.88±14.88	80.35±8.87
Diabetes mellitus (%)	41.9^f	7.7	12.5
Smoking or addiction (%)	51.6	35.5	12.5
Hypertension (%)	64.5	46.2	41.7
Hyperlipidemia (%)	51.6	38.5	22.2

Values are presented as mean ± SD. FBS: fasting blood sugar; BMI: body mass index; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides; SBP: systolic blood pressure; DBP: diastolic blood pressure. Compared with the control group: aP < 0.05, bP < 0.01, and cP < 0.001; compared with the CAD⁻ group: dP < 0.01, eP < 0.001; comparison between all groups (using Chi-square test): fP < 0.05, gP < 0.001.